Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by madtrader2on Mar 30, 2020 10:04pm
169 Views
Post# 30862606

Pure Sunfarms

Pure Sunfarms

Pure Sunfarms' (Cannabis Joint Venture) Financial Results for the Year Ended December 31, 2019
(All comparable figures are for the year ended December 31, 2018.)

•Net sales (before Village Farms' proportionate share), which consisted entirely of dried cannabis, were C$82.8 million (US$62.3 million) compared with C$4.9 million (US$3.7 million);

•"All-in" cost of cultivation (including depreciation) was C$0.78 (US$0.59) per gram;

•Gross margin was 76% compared with 69%;

•Selling, general and administrative expenses (before Village Farms' proportionate share) were C$10.4 million (US$7.9 million) compared with C$3.4 million (US$2.5 million);

•Net income (before Village Farms' proportionate share) of C$36.5 million (US$27.4 million); and,

•EBITDA (before Village Farms' proportionate share) was C$54.1 million (US$40.7 million), resulting in an EBITDA margin of 65%, compared with C$0.3 million (US$0.2 million).

<< Previous
Bullboard Posts
Next >>